Govt of Punjab, Roche Pharma India and Niramai Health Analytix joint venture to quicken Breast Cancer management

Department of Health & Family Welfare, Government of Punjab, Roche Pharma India and Niramai Health Analytix has jointly united as part of Punjab Breast Cancer AI-Digital project to accelerate screening and treatment for Breast Cancer

CanSinoBIO's mRNA COVID vaccine candidate has been approved for clinical trials in China

Chinese vaccine developer CanSino Biologics Inc said on Monday its potential COVID-19 vaccine using the messenger RNA technology has been accepted by China's medical products regulator to enter clinical trials.

SII's Covovax for aged 12+ gets panel nod

The Covid-19 working group under the government’s vaccine advisory body has recommended use of the Serum Institute of India’s Covovax

Dr Reddy's buys Novartis cardiovascular drug Cidmus in India for Rs 456 crore

Dr. Reddy's on Friday said it has entered into an agreement with Novartis to acquire the cardiovascular brand Cidmus in India for Rs 456 crore ($61 million).

How Deep Learning can Strengthen Pharmaceutical Research

In the last one decade, people have witnessed the increasing sophistication of machine learning algorithms applied in daily use from internet searches, voice recognition, social network software to machine vision software in cameras, phones,

Mexico in talks with india for vaccine and cancer drug technology

Mexican Foreign Minister Marcelo Ebrard has begun talks to receive medical technology from Indian companies to develop vaccines and cancer drugs in Mexico on Wednesday, the ministry said.

WHO selects Biological E as mRNA technology recipient

The World Health Organization’s Product Development for Vaccines Advisory Committee yesterday selected Biological E as a recipient of mRNA technology from the WHO technology transfer hub.

Mission Therapeutics has begun a clinical trial for the treatment of kidney disease

MTX652 has advanced through preclinical regulatory toxicology studies and is ready for a phase 1 trial.

USFDA issues 13 observations to Lupin's New Jersey plant

Drug maker Lupin on Thursday told, its New Jersey facility has received 13 observations from the US drug regulator.

Novel Curative Therapies to Disrupt the Pharma Industry

In the coming days curative therapies will change the face of the healthcare system.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.